Mayo Clinic
Rochester, Minnesota, 55901, United States
NCT Number: NCT01161953
Primary Biliary Cirrhosis (PBC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PBC.
This study is being done to investigate whether genes make people more likely to develop PBC. Discovery of these proposed genes will help us better understand how PBC developes, and subsequently, to apply new approaches for its prevention, diagnosis and treatment.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Rochester, Minnesota, 55901, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Perform Genome Wide Association Studies.
Adult chronic cholestatic liver diseases, such as Primary Biliary Cirrhosis (PBC), are progressive liver disorders of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PBC.
This study is being done to investigate whether genes (the inherited genetic material passed from parents to their children) make people more likely to develop PBC. Discovery of these proposed genes will help us to better understand how PBC progresses, and subsequently, to apply new approaches for its prevention, diagnosis and treatment.
Mayo Clinic
Other
Understanding the Genetic Predisposition to the Development of Primary Biliary Cirrhosis (PBC).
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03743272
Autoimmune Diseases, Autoimmune Hepatitis
Leiden, Netherlands
View Trial DetailsNCT02846896
Bile Duct Diseases, Biliary Tract Diseases
Lugano, Switzerland
View Trial DetailsNCT03112681
Bile Duct Diseases, Biliary Tract Diseases
Pasadena, California, United States
View Trial DetailsNCT04522869
Bile Duct Diseases, Biliary Atresia
Hanoi, Vietnam
View Trial Details